Group 1: Financial Performance - In the first three quarters of 2025, the company's operating revenue was 141,205.37 million CNY, with a net profit attributable to shareholders of 4,639.62 million CNY [3] - The share-based payment expenses for the same period amounted to 1,524.78 million CNY, leading to a net profit of 6,164.40 million CNY after adjustments, representing a year-on-year growth of 12.96% [3] - The net profit excluding non-recurring gains and losses was 5,822.06 million CNY, reflecting a 13.35% increase compared to the previous year [3] Group 2: International Business Strategy - The company has seen a steady increase in overseas business, with foreign sales revenue for 2022, 2023, and 2024 being 36,252.59 million CNY, 58,031.95 million CNY, and 73,031.44 million CNY respectively, accounting for 18.81%, 24.60%, and 37.53% of total revenue [5] - In the first half of 2025, overseas business revenue reached 39,589.88 million CNY, making up 44.16% of total revenue, with a year-on-year growth of 20.91% [5] Group 3: Strategic Acquisitions and Integration - The acquisition of Hefei Shengbang Electric Co., Ltd. is aimed at enhancing the company's core competitiveness and optimizing the industrial chain [4] - Post-acquisition, the company is focusing on organizational structure, strategic synergy, financial systems, business integration, and cultural development, with integration progressing as planned [4] Group 4: Market Outlook and Business Structure - The home appliance industry is currently undergoing structural adjustments, with traditional large appliance markets slowing down, while trends towards high-end, smart, and green products are emerging [4] - The company is not deviating from its main business but is optimizing its business structure through a strategy of strengthening its core business, upstream collaboration, and international expansion [4] Group 5: Shareholder Information - The major shareholders include Gu Wei, Anhui Zhidao Investment Co., Ltd., and Ningbo Xueqi Enterprise Management Partnership [6] - A reduction plan for shareholders was disclosed in April 2025, with the shareholding of one shareholder dropping below 5% after the plan was executed [6]

Group 1: Pharmaceutical Business Performance - In the first half of 2025, the pharmaceutical segment achieved a revenue of CNY 4.751 billion, representing a year-on-year growth of 10.8% [2] - Sales revenue of Yunnan Baiyao aerosol exceeded CNY 1.453 billion, with a significant year-on-year increase of over 20.9% [2] - Other traditional Chinese medicine products showed remarkable growth, with sales of Canling Jianpi Granules exceeding CNY 100 million and Pudilan Anti-inflammatory Tablets nearing CNY 100 million [2] - Plant-based products, such as Qixue Kang Oral Liquid, reached sales of CNY 202 million, with a year-on-year growth of approximately 116.2% [2] Group 2: Nuclear Medicine R&D Progress - The INR101 diagnostic nuclear medicine project has initiated Phase III clinical trials, with 32 research centers established and 22 activated, enrolling 60 subjects [3] - The INR102 therapeutic nuclear medicine project has received a clinical trial notification, with Phase I trials underway and 12 patients enrolled for Phase II trials [3] Group 3: Health Products Business Performance - The health products segment reported a revenue of CNY 3.442 billion in the first half of 2025, reflecting a year-on-year growth of 9.46% [4] - The segment focuses on a full-channel operation strategy, enhancing offline distribution capabilities and increasing online channel investments [4] - The oral care category, particularly gum care toothpaste, maintains and gradually expands its leading advantage, while anti-sensitivity toothpaste shows breakthrough growth [4] Group 4: Online Sales Performance - The pharmaceutical segment's online sales increased by over 20% year-on-year, with a GMV of CNY 254 million generated from 4.845 million visitors [5] - Yunnan Baiyao toothpaste holds the top market share in the domestic all-channel market, while Yangyuanqing shampoo ranked first in Tmall's domestic anti-hair loss category during the 2025 "618" shopping festival [5] Group 5: Dividend Distribution - For the 2024 fiscal year, the company distributed a cash dividend of CNY 11.85 per 10 shares, totaling CNY 2.164 billion [6] - The total cash dividend for 2024, including special dividends, amounted to CNY 23.98 per 10 shares, representing 90.09% of the net profit attributable to shareholders [7] - In the first half of 2025, the company distributed a cash dividend of CNY 10.19 per 10 shares, totaling CNY 1.818 billion, with special dividends accounting for 50.05% of the net profit for the period [7]

Group 1: Investor Relations Activity - The meeting was categorized as a specific object survey [2] - Participants included representatives from CITIC Securities and Prudential Asset Management [2] - The meeting took place on November 21, 2025, at the Group's headquarters [2] Group 2: Purpose of the Meeting - The main objective was to understand the company's production and operational status [2] - The meeting involved direct communication with the company's board secretary and investor relations management [2]

Financial Performance - The company achieved a total revenue of 553 million CNY in Q3 2025, representing a year-on-year growth of 32.94% [2] - The net profit attributable to shareholders was approximately 123 million CNY, with a year-on-year increase of 47.05% [2] - The net profit excluding non-recurring gains and losses was about 115 million CNY, reflecting a growth of 62.37% year-on-year [2] Factors Influencing Profit Growth - Significant profit increase is attributed to continuous optimization of product structure and internal efficiency improvements [3] Production and Capacity Expansion - The company has a strong order backlog for drill bits, with high capacity utilization and some products facing tight delivery schedules [4] - To meet demand fluctuations, the company is accelerating the construction of its PCB micro drill bit production base and plans to expand capacity in an orderly manner based on market conditions [4] - The maximum monthly production capacity of self-manufactured equipment is approximately 5 million drill bits [5] Raw Material Cost Management - The rising tungsten prices have a controllable direct impact on costs; the company is implementing multiple measures to mitigate this [6] - Strategies include technological innovation, process optimization, and maintaining stable long-term relationships with suppliers [6] Technological Adaptation - The company is closely monitoring technological trends in the industry and has made comprehensive technical arrangements to address potential risks from alternative materials [7] - It has developed a range of solutions for high-end PCB applications and is prepared to adapt based on market demands [7] Business Integration and Future Plans - The integration of the German subsidiary with MPK has been successfully completed, leading to efficient collaboration in technology, market, and management [8] - Future capacity planning will be based on market developments to enhance local production and service capabilities [8] Fundraising and Strategic Goals - The upcoming H-share issuance aims to raise funds for global capacity expansion, R&D in cutting-edge technologies, and digital operational systems [9] - The planned issuance will not exceed 10% of the total share capital post-issuance, with an additional 15% over-allotment option for underwriters [9] Performance Outlook - The company is optimistic about achieving its performance targets for the current year and aims for higher goals in 2026 [10]

Group 1: Market Applications - The company is entering mainstream industries for HDI, including coatings, automotive paints, wood coatings, and industrial paints, while also focusing on emerging applications in polyurethane new materials [2] - PPDI exhibits superior physical and mechanical properties, making it suitable for high-end elastomer materials used in aerospace, high-end automotive shock absorbers, oil drilling equipment seals, and coal mining conveyor belts [2] Group 2: Product Utilization - The company has started using products from its subsidiary in Henan, replacing some externally sourced materials for the production of specialty new materials like TPU, thereby reducing reliance on external suppliers and controlling supply chain risks [3] - The company has completed capital increase in Henan, resulting in a holding ratio of approximately 70% [3] Group 3: Future Innovations - TPU materials show potential for applications in emerging fields such as robotic skin, with the company actively exploring innovative applications in high-performance materials to seize future market opportunities [3]

Group 1: Company Performance and Market Impact - The company's main business revenue decreased by 15.40% year-on-year in the first three quarters of 2025, influenced by significant price drops in key products due to national drug procurement policies [3][4] - Products entering national procurement saw price reductions exceeding 50%, while those in provincial and local procurement experienced an average price drop of around 15% [3] - Key products like Lenalidomide and Metronidazole have dropped out of the top ten revenue-generating products, indicating a shift in the company's revenue sources [3] Group 2: New Product Developments - Recent new products that won national procurement include Voriconazole tablets and Vildagliptin tablets, which are becoming mainstay products for the company [4] - The company has also introduced a unique dosage form of Nitroglycerin spray, which has good market potential and is now available for purchase [7][9] - The company is developing several new drugs, including GLP-1 formulations for diabetes treatment, which are in the final stages of clinical research [11] Group 3: Investment Activities - The company invested 10 million yuan in Changfeng Pharmaceutical in 2010, which is now valued at nearly 500 million yuan following its listing on the Hong Kong Stock Exchange [5] - The company holds a 20% stake in Beijing Hengtai Kang Pharmaceutical Technology Co., which is developing a unique probiotic lozenge [7] - The company prefers equity investments in promising firms rather than acquisitions, to avoid burdening its operational focus [12] Group 4: Sales and Marketing Strategies - The company has shifted from a primarily hospital-based sales model to include e-commerce platforms, with online sales increasing year by year [10] - Efforts are being made to enhance product market penetration and expand sales channels, particularly through partnerships with various pharmaceutical sales platforms [10] Group 5: Future Outlook - The company anticipates that the impact of price reductions from national procurement will weaken if no major products enter procurement in the near future [12] - There is a need for increased R&D efforts and faster product launches to boost main business revenue moving forward [12]

Group 1: Project Development - The company is currently advancing its "200,000 tons/year Anthraquinone Deep Processing Project" and "Supplementing Working Capital" with an expected construction period of 18 months [2] - The project aims to produce 50,000 tons of Anthraquinone and 20,000 tons of Decant Oil, with Decant Oil being used entirely in-house, while the Anthraquinone and Decant Oil will generate revenue through external sales [2] Group 2: Energy Utilization Advantages - The company has established a carbon black tail gas power generation facility, which allows for self-supply of electricity for production and office use, significantly reducing electricity costs [3] - Through technical modifications, the company utilizes tail gas from carbon black production to generate steam for turbines and directly drive production fans, enhancing equipment efficiency [3] Group 3: Circular Economy Strategy - Since its establishment, the company has focused on extending and efficiently utilizing the coal tar deep processing industry chain, aiming for high-quality carbon black products and fine chemical products [3] - The integration of "coal tar processing + carbon black production + tail gas power generation + fine chemical new materials" forms a sustainable circular industry model, promoting high-end differentiation and scale of carbon black products [3]

Company Overview - Hengyi Petrochemical Co., Ltd. is a leading integrated enterprise in the "refining-chemical-fiber" industry chain, focusing on a strategic positioning of "one drop of oil, two strands of silk" [2][3] - The company has established a unique dual-main business model of "polyester + nylon" through the Brunei refining project, creating a closed-loop from crude oil processing to chemical fiber products [2][3] Financial Performance - In the first three quarters of 2025, the company achieved a revenue of CNY 83.885 billion and a net profit attributable to shareholders of CNY 231 million, with a year-on-year net profit growth of 0.08% [4] - As of September 30, 2025, total assets amounted to CNY 1115.10 billion, and net assets attributable to shareholders were CNY 24.458 billion [4] Market Insights Southeast Asia Oil Market - Southeast Asia is the largest net importer of refined oil globally due to insufficient infrastructure investment, despite having rich oil and gas resources [4][5] - The region's oil demand is projected to increase from 5 million barrels per day to 6.4 million barrels per day by 2035, with Southeast Asia expected to account for 25% of global energy demand growth in the next decade [4][5] Polyester Industry Outlook - The company holds a leading position in polyester production, with a diversified product range including long fibers, short fibers, and chips [6][7] - Domestic retail sales in China grew by 5% in the first half of 2025, with the textile sector seeing a 3.1% increase, while fiber and textile exports rose by 12% [6][7] Project Developments Qinzhou Project - The Qinzhou project aims for an annual production capacity of 1.2 million tons of caprolactam and nylon, with the first phase recently entering trial production [8][9] - The project integrates advanced proprietary technologies, optimizing energy consumption and production costs, and is expected to significantly enhance the company's competitive position in the nylon market [8][9] Convertible Bonds - The company decided not to adjust the conversion price of Hengyi convertible bonds and Hengyi Convertible 2, maintaining investor confidence amid market fluctuations [10]

Group 1: Company Progress and Investments - The company has obtained CNAS authorization for nearly 40 standards related to intelligent unmanned equipment testing, covering military and civilian applications [2] - The "Intelligent Emergency Equipment Testing Industrial Park" project commenced construction on May 27, 2025, and is currently in the civil engineering phase, with an estimated total investment return rate of 9.61% and a post-tax investment recovery period of 11.21 years [2] Group 2: Capacity Utilization and Network Layout - The capacity utilization rate of various testing bases remains at a reasonable level, with a focus on market-oriented, international, and specialized development [3] - The company has established a national testing base network with clear functional positioning and complementary capabilities, covering over 20 business departments across various provinces and cities [3] Group 3: New Energy Vehicle Testing Expansion - The company is actively expanding its business in the new energy vehicle testing sector, having established key testing facilities for batteries, motors, and electronic controls [4] - Since the operation of the new energy three-electric laboratory, the company has seen steady growth in customer numbers and business revenue, with significant growth in new energy vehicle-related testing services in 2025 [4]

Group 1: Overseas Expansion and Production Capacity - The company has initiated overseas capacity planning, starting with preliminary research in Southeast Asia since 2024, including the establishment of a subsidiary in Singapore [2] - The construction of a production base in Vietnam is currently on hold due to changes in U.S. tariff policies, with plans to proceed once the policies are clarified [3] Group 2: North American Operations - The company is implementing a localization strategy in North America, having established subsidiaries in California and Texas to serve local markets [4] - The U.S. subsidiaries focus on processing manufacturers, brand clients, and channel partners, using the "Yuma" brand for sales [4] Group 3: Impact of Tariff Policies - Recent changes in tariff policies have caused temporary disruptions in orders from the U.S., but adjustments have led to renewed focus on supply chain stability and product quality [5] - The company has not seen a significant impact on customer cooperation due to its enhanced local operations and service [5] Group 4: Product Pricing and Profit Margins - The company's products typically have significant markup after processing and branding, with customized products offering even higher profit margins [6] - The focus is on product differentiation and technical services to enhance value rather than relying solely on price competition [6] Group 5: Sales Performance of Dream Curtain Product - The Dream Curtain product has experienced a phase of market adjustment after rapid growth, with domestic sales declining but international sales increasing [8] - The product maintains a competitive edge due to its multifunctionality, and the company is increasing export efforts to tap into new growth opportunities [8] Group 6: Market Share and Future Growth Drivers - The company currently holds a low market share in key global markets, indicating significant potential for growth [9] - Future growth is expected to be driven by new high-performance materials, improved sales channel layouts, operational efficiency, and flexible production capacity [9]